Table of Contents

October 20, 2005
Volume 48, Issue 21
Pages 6523-6766

About the Cover: Illustration of the binding mode of a biheteroaryl inhibitor to vascular endothelial growth factor receptor-2 (Kuo, G.-H.; et al. J. Med. Chem. 2005, 48, 1886-1900).

Perspective

Designed Multiple Ligands. An Emerging Drug Discovery Paradigm

pp 6523–6543
Publication Date (Web): September 24, 2005 (Perspective)
DOI: 10.1021/jm058225d

Letters

Structure-Based Design and Discovery of Protein Tyrosine Phosphatase Inhibitors Incorporating Novel Isothiazolidinone Heterocyclic Phosphotyrosine Mimetics

pp 6544–6548
Publication Date (Web): September 23, 2005 (Letter)
DOI: 10.1021/jm0504555

Selective Inhibition of MCF-7piGST Breast Tumors Using Glutathione Transferase-Derived 2-Methylene-cycloalkenones

pp 6549–6552
Publication Date (Web): September 21, 2005 (Letter)
DOI: 10.1021/jm058245f

Articles

Introduction of a cis-Prolyl Mimic in Position 7 of the Peptide Hormone Oxytocin Does Not Result in Antagonistic Activity

pp 6553–6562
Publication Date (Web): September 17, 2005 (Article)
DOI: 10.1021/jm049205z

G-Protein-Coupled Receptor Affinity Prediction Based on the Use of a Profiling Dataset:  QSAR Design, Synthesis, and Experimental Validation

pp 6563–6574
Publication Date (Web): September 22, 2005 (Article)
DOI: 10.1021/jm0500673

Multiple-Ligand-Based Virtual Screening:  Methods and Applications of the MTree Approach

pp 6575–6584
Publication Date (Web): September 20, 2005 (Article)
DOI: 10.1021/jm050078w

Receptor Flexibility in de Novo Ligand Design and Docking

pp 6585–6596
Publication Date (Web): September 22, 2005 (Article)
DOI: 10.1021/jm050196j

Synthesis and Antimuscarinic Properties of Quinuclidin-3-yl 1,2,3,4-Tetrahydroisoquinoline-2-carboxylate Derivatives as Novel Muscarinic Receptor Antagonists1

pp 6597–6606
Publication Date (Web): September 28, 2005 (Article)
DOI: 10.1021/jm050099q

Hydroxyethylene Sulfones as a New Scaffold To Address Aspartic Proteases:  Design, Synthesis, and Structural Characterization

pp 6607–6619
Publication Date (Web): September 16, 2005 (Article)
DOI: 10.1021/jm050224y

Angiotensin II Pseudopeptides Containing 1,3,5-Trisubstituted Benzene Scaffolds with High AT2 Receptor Affinity

pp 6620–6631
Publication Date (Web): September 23, 2005 (Article)
DOI: 10.1021/jm050280z

Heteroaryl-Substituted Naphthalenes and Structurally Modified Derivatives:  Selective Inhibitors of CYP11B2 for the Treatment of Congestive Heart Failure and Myocardial Fibrosis

pp 6632–6642
Publication Date (Web): September 22, 2005 (Article)
DOI: 10.1021/jm0503704

Discovery of Iodinated Somatostatin Analogues Selective for hsst2 and hsst5 with Excellent Inhibition of Growth Hormone and Prolactin Release from Rat Pituitary Cells

pp 6643–6652
Publication Date (Web): September 28, 2005 (Article)
DOI: 10.1021/jm050376t

Improving the Antiviral Efficacy and Selectivity of HIV-1 Reverse Transcriptase Inhibitor TSAO-T by the Introduction of Functional Groups at the N-3 Position

pp 6653–6660
Publication Date (Web): September 24, 2005 (Article)
DOI: 10.1021/jm050437n

Investigation of the Binding Determinants of Phosphopeptides Targeted to the Src Homology 2 Domain of the Signal Transducer and Activator of Transcription 3. Development of a High-Affinity Peptide Inhibitor

pp 6661–6670
Publication Date (Web): September 16, 2005 (Article)
DOI: 10.1021/jm050513m

Ring Systems in Mutagenicity Databases

pp 6671–6678
Publication Date (Web): September 21, 2005 (Article)
DOI: 10.1021/jm050564j

Antibiotic Binding to Monozinc CphA β-Lactamase from Aeromonas hydropila:  Quantum Mechanical/Molecular Mechanical and Density Functional Theory Studies

pp 6679–6689
Publication Date (Web): September 17, 2005 (Article)
DOI: 10.1021/jm0505112

Development of Nonsymmetrical 1,4-Disubstituted Anthraquinones That Are Potently Active against Cisplatin-Resistant Ovarian Cancer Cells

pp 6690–6695
Publication Date (Web): September 15, 2005 (Article)
DOI: 10.1021/jm050438f

Perhydroquinolylbenzamides as Novel Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1

pp 6696–6712
Publication Date (Web): September 16, 2005 (Article)
DOI: 10.1021/jm058228q

Synthesis and Structure−Activity Relationships of β- and α-Piperidine Sulfone Hydroxamic Acid Matrix Metalloproteinase Inhibitors with Oral Antitumor Efficacy

pp 6713–6730
Publication Date (Web): September 21, 2005 (Article)
DOI: 10.1021/jm0500875

Preliminary Studies of New Proteasome Inhibitors in the Tumor Targeting Approach: Synthesis and in Vitro Cytotoxicity

pp 6731–6740
Publication Date (Web): September 27, 2005 (Article)
DOI: 10.1021/jm050181l

Structure−Activity Relationship Study on a Simple Cationic Peptide Motif for Cellular Delivery of Antisense Peptide Nucleic Acid

pp 6741–6749
Publication Date (Web): September 15, 2005 (Article)
DOI: 10.1021/jm050490b

Glucosamine-glycerophospholipids That Activate Cell-Matrix Adhesion and Migration

pp 6750–6755
Publication Date (Web): September 14, 2005 (Article)
DOI: 10.1021/jm050558n

Brief Articles

A Novel Selective GABAA α1 Receptor Agonist Displaying Sedative and Anxiolytic-like Properties in Rodents

pp 6756–6760
Publication Date (Web): September 23, 2005 (Brief Article)
DOI: 10.1021/jm058002n

Mechanisms of Cytotoxicity of Selected Organogold(III) Compounds

pp 6761–6765
Publication Date (Web): September 24, 2005 (Brief Article)
DOI: 10.1021/jm050493o

Additions and Corrections

Highly Potent 1,4-Benzo-thiazine Derivatives as KATP-Channel Openers

p 6766
Publication Date (Web): September 17, 2005 (Addition/Correction)
DOI: 10.1021/jm0580407